David Schwartzman
About
In The Last Decade
David Schwartzman
39 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 78
- Cardiology and Cardiovascular Medicine 911
- Surgery 88
- Neurology 77
- Radiology, Nuclear Medicine and Imaging 76
- Biomedical Engineering 48
Countries citing papers authored by David Schwartzman
This map shows the geographic impact of David Schwartzman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Schwartzman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Schwartzman more than expected).
Fields of papers citing papers by David Schwartzman
This network shows the impact of papers produced by David Schwartzman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Schwartzman. The network helps show where David Schwartzman may publish in the future.
Co-authorship network of co-authors of David Schwartzman
This figure shows the co-authorship network connecting the top 25 collaborators of David Schwartzman. A scholar is included among the top collaborators of David Schwartzman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Schwartzman. David Schwartzman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 2 | |
| 3 | The Contribution of Education to the Quality of Labor: Reply | 0 |
| 4 | 24 | |
| 5 | 14 | |
| 6 | 0 | |
| 7 | 1 | |
| 8 | 1 | |
| 9 | 2 | |
| 10 | 14 | |
| 11 | 29 | |
| 12 | 1 | |
| 13 | 103 | |
| 14 | 5 | |
| 15 | 2 | |
| 16 | 17 | |
| 17 | 6 | |
| 18 | 3 | |
| 19 | 1 | |
| 20 | The expected return from pharmaceutical research : sources of new drugs and the profitability of R & D investment | 2 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.